AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Antispasmodic Action: Methylatropine nitrate acts as an antimuscarinic agent, meaning it blocks the action of acetylcholine at muscarinic receptors. By doing so, it inhibits the involuntary contractions of smooth muscles, particularly in the GI tract and the urinary system. This action helps to relieve spasms and cramps in these organs.
Gastrointestinal Disorders: Methylatropine nitrate is commonly used to alleviate symptoms associated with gastrointestinal disorders such as irritable bowel syndrome (IBS), gastric ulcers, diverticulitis, and other conditions characterized by spasms or cramps in the GI tract. It can help reduce abdominal pain, bloating, and discomfort.
Urinary Disorders: Methylatropine nitrate may also be used to treat urinary disorders characterized by involuntary muscle contractions, such as overactive bladder or urinary incontinence. By reducing bladder spasms, it can help improve urinary control and reduce urgency and frequency of urination.
Preoperative Medication: Methylatropine nitrate is sometimes administered before surgery to reduce secretions in the respiratory and GI tracts. By drying up these secretions, it can help prevent complications such as aspiration pneumonia during anesthesia.
Adjunctive Therapy: In some cases, methylatropine nitrate may be used as adjunctive therapy in the treatment of certain medical conditions, particularly those involving spasms or hypersecretion.
Side Effects: Like all medications, methylatropine nitrate may cause side effects. Common side effects may include:
Contraindications: Methylatropine nitrate is contraindicated in individuals with a known hypersensitivity to the medication or its components. It should also be used with caution in patients with certain medical conditions such as glaucoma, prostatic hypertrophy, or obstructive urinary disorders.
Dosage and Administration: The dosage of methylatropine nitrate is individualized based on the patient's condition and response to treatment. It is typically administered orally in the form of tablets or as an injection for intramuscular or intravenous use.
Monitoring: Patients taking methylatropine nitrate should be monitored for adverse effects, particularly those related to anticholinergic activity such as dry mouth, urinary retention, and constipation. Dosage adjustments may be necessary based on the patient's response and tolerance to the medication.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]